MYDA Advisors’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$321K Buy
+30,000
New +$335K 0.04% 175
2024
Q3
– Sell
-20,000
Closed -$412K – 175
2024
Q2
$412K Sell
20,000
-6,000
-23% -$123K 0.09% 95
2024
Q1
$555K Buy
26,000
+1,000
+4% +$19.4K 0.16% 82
2023
Q4
$360K Sell
25,000
-55,000
-69% -$541K 0.12% 71
2023
Q3
$730K Hold
80,000
– – 0.24% 62
2023
Q2
$846K Buy
80,000
+60,000
+300% +$710K 0.25% 71
2023
Q1
$245K Hold
20,000
– – 0.09% 95
2022
Q4
$248K Hold
20,000
– – 0.15% 67
2022
Q3
$273K Hold
20,000
– – 0.13% 109
2022
Q2
$367K Hold
20,000
– – 0.1% 132
2022
Q1
$322K Buy
+20,000
New +$289K 0.13% 136

Other funds holding KURA

MYDA Advisors's KURA Position: Q3 2026 in Review

MYDA Advisors opened a new position in Kura Oncology (KURA) in Q3 2026: 30,000 shares worth $321K. The stake represents 0.04% of the portfolio and ranks #175 among its holdings. This is a return to the name: MYDA Advisors previously reported a position in KURA as recently as Q2 2024.

MYDA Advisors first reported a position in KURA in Q1 2022 and has held it in 11 quarters since. The position peaked at $846K in Q2 2023. 233 funds tracked by Wall St. Rank hold KURA as of Q3 2026.

  • MYDA Advisors held 30,000 shares of Kura Oncology worth $321K as of Q3 2026.
  • Kura Oncology was a new MYDA Advisors position in Q3 2026.
  • Kura Oncology made up 0.04% of MYDA Advisors's portfolio in Q3 2026, its #175 holding.
  • MYDA Advisors first reported a position in Kura Oncology in Q1 2022 and has held it in 11 quarters since.
  • MYDA Advisors's Kura Oncology position peaked at $846K in Q2 2023.
  • 233 funds tracked by Wall St. Rank held Kura Oncology as of Q3 2026.

Based on MYDA Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.